Erik Birkeneder is an intellectual property attorney at Nixon Peabody focused on digital health and medical device companies. Artificial intelligence originally aspired to replace doctors. Researchers imagined robots that could ask you questions, run the answers through an algorithm that would learn with experience and tell whether you had the flu or a cold. However, those promises largely failed, as artificial intelligent algorithms were too rudimentary to perform those functions. Particularly tricky was the variability between people, which caused basic machine learning algorithms to miss the patterns.

The ortho giant's purchase of French surgical robotics firm Medtech could give competitor Mazor Robotics a run for its money, according to one analyst. Zimmer Biomet has officially entered the surgical robotics market with its acquisition of a majority of shares in the French firm Medtech, maker of a robotics platform for neurological and spine procedures. The Warsaw, IN-based company, a leader in the musculoskeletal space, announced July 18 that it had purchased almost 59% of shares in Medtech and also intends to mount an all-cash simplified tender offer to acquire the remaining shares. Zimmer Biomet will continue to operate Medtech out of its current headquarters in Montepellier, France, which will also serve as a "center of excellence" for Zimmer Biomet's surgical robotics development efforts, according to a joint press release from the companies. With the Medtech acquisition, Zimmer Biomet gains the Rosa platform, which is currently used in 20 hospitals in Europe, North America, Asia, and the Middle East, according to the company's website.

Even before we discuss the impact of Artificial Intelligence on Immigration, its important to understand on how countries benefit from Immigration.Every country wants to attract best talent in the world. Talented citizens will help generate further jobs and expand economy. Skilled labour is always in demand and hence almost every country has immigration program for skilled labour. Now on Artificial Intelligence- development of computer systems that are able to perform tasks that normally require human intelligence. Some of the recent Artificial Achievement advancements in various industries:Healthcare Major medical and pharmaceutical companies are already harnessing the power of artificial intelligence with great results.

Segway creator Dean Kamen's Luke prosthetic arm has been a long time in coming -- the FDA approved it two years ago. Mobius Bionics has revealed that it will offer the Luke arm sometime in late 2016. It's not clear what it will take to get one (you can register your interest today), but the features remain the same. The bionic wearable is all about offering the life-like dexterity that hasn't really been an option until now: you can hold a glass over your head without spilling it, for example, and the hand's mix of four motors and grip sensors can help you grab both very delicate and very heavy items. The odds are that getting one won't be trivial, but it might well be justified if it grants some extra freedom.

Stealthy MedyMatch emerged in February with plans to improve emergency room care using cognitive analysis and artificial intelligence. Now, in its first collaboration with a U.S. hospital, the company is developing its first real-time decision-support tool using data from New Jersey-based Capital Health. Under the agreement, Capital Health will supply Israel-based MedyMatch with anonymized data to help it develop the tool, which will target stroke patients. It will analyze medical images and provide the ER radiologist with information to help him or her determine the course of treatment. It combines "deep vision, advanced cognitive analytics and artificial intelligence" to analyze images and identify anomalies that may be invisible to the human eye.

Artificial intelligence may be the new face of medical diagnostics. For the first time, a flavor of A.I. called deep learning is being implemented in new ultrasound imaging equipment to aid in breast exams and help patients avoid unnecessary biopsies. A new feature in Samsung Medison's ultrasound system uses a deep-learning algorithm to make recommendations about whether a breast abnormality is benign or cancerous. The "S-Detect for Breast" feature is now included in an upgrade to the company's RS80A ultrasound system and is commercially available in parts of Europe, the Middle East and Korea and is pending FDA approval in the U.S., according to PR manager Doug Kim. Deep learning relies on large amounts of data to inform complex decision-making algorithms, has aided in everything from speech and image recognition software to pharmaceutical research.

Samsung Medison's new ultrasound system quickly screens for abnormalities. Artificial intelligence may be the new face of medical diagnostics. For the first time, a flavor of A.I. called deep learning is being implemented in new ultrasound imaging equipment to aid in breast exams and help patients avoid unnecessary biopsies. A new feature in Samsung Medison's ultrasound system uses a deep-learning algorithm to make recommendations about whether a breast abnormality is benign or cancerous. The "S-Detect for Breast" feature is now included in an upgrade to the company's RS80A ultrasound system and is commercially available in parts of Europe, the Middle East and Korea and is pending FDA approval in the U.S., according to PR manager Doug Kim.

In the future, will artificial intelligence be so sophisticated that it will be able to tell when someone is trying to deceive it? A Carnegie Mellon University professor and his team is working on technology that could move this idea from the realm of science fiction to reality. Their work -- rooted in game theory and machine learning -- is part of a larger push for more advanced AI. As AI becomes more commonplace in the technology we use every day, detractors and supporters are becoming more vocal about its potential risks and benefits. For some, smarter AI sets up a dangerous precedent for a future too reliant on machines to make decisions about everything from medical diagnoses to the operation of self-driving cars.

In the future, will artificial intelligence be so sophisticated that it will be able to tell when someone is trying to deceive it? A Carnegie Mellon University professor and his team is working on technology that could move this idea from the realm of science fiction to reality. Their work -- rooted in game theory and machine learning -- is part of a larger push for more advanced AI. As AI becomes more commonplace in the technology we use every day, detractors and supporters are becoming more vocal about its potential risks and benefits. For some, smarter AI sets up a dangerous precedent for a future too reliant on machines to make decisions about everything from medical diagnoses to the operation of self-driving cars.

BPM 31510 is just another cancer drug in human development trials, except for one thing. Scientists didn't toil away in labs to come up with it; artificial intelligence did. The cancer drug development process is costly and time-consuming. On average, it takes 24 to 48 months and upwards of 100 million to find a suitable candidate. Add that to the fact that 95% of all potential drugs fail in clinical trials, and the inefficiencies of the whole drug-discovery machine really become apparent.